Combined therapy makes headway for liver cancer
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without
Source: newswise.com
📰 Chul Ahn News
Chul Ahn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chul Ahn. Real-time updates on events, politics, business and more.
Combined therapy makes headway for liver cancer
A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without
Source: newswise.com
New clinical trial may establish a standard of care for patients with oligometastatic kidney cancer
Kidney cancer encompasses a wide spectrum and can present with extensive metastases or just a handful. However, today all patients are treated the same. They all receive medication.
Source: news-medical.net